Beximco Pharmaceuticals Limited (BST:R2WA)
0.4220
0.00 (0.00%)
At close: Jul 23, 2025
Beximco Pharmaceuticals Market Cap
Beximco Pharmaceuticals has a market cap or net worth of €329.43 million as of July 25, 2025. Its market cap has decreased by -9.91% in one year.
Market Cap
329.43M
Enterprise Value
380.29M
Revenue
373.79M
Ranking
n/a
PE Ratio
6.43
Stock Price
€0.42
Market Cap Chart
Since January 3, 2000, Beximco Pharmaceuticals's market cap has increased from 36.78M to 329.43M, an increase of 795.77%. That is a compound annual growth rate of 8.95%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jul 24, 2025 | 329.43M | 12.67% |
Dec 30, 2024 | 292.37M | -45.57% |
Dec 28, 2023 | 537.15M | -9.71% |
Dec 29, 2022 | 594.94M | -33.15% |
Dec 30, 2021 | 889.99M | 9.12% |
Dec 30, 2020 | 815.57M | 175.99% |
Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
SAP SE | 286.61B |
Siemens Aktiengesellschaft | 176.81B |
Deutsche Telekom AG | 155.87B |
Allianz SE | 131.67B |
Rheinmetall AG | 79.89B |
Siemens Energy AG | 76.54B |
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 74.30B |
Deutsche Bank Aktiengesellschaft | 55.59B |